TFOS blog
  • Home
  • About
  • www.tearfilm.org

Patient-Focused Summary of TFOS DEWS II Report Announced for Dry Eye Awareness Month 2019

By admin • 24 July 2019 • Dry Eye Disease, TFOS DEWS II

PRESS RELEASE
FOR IMMEDIATE RELEASE
July 24, 2019

Tear Film & Ocular Surface Society
Amy Gallant Sullivan
amy@tearfilm.org
@Eyeppl

(Boston, MA) Today, in recognition of Dry Eye Awareness Month, TFOS announced the availability of the patient-focused Executive Summary of the TFOS DEWS II Report. Creation of this document was prompted by the recognition that it is very important for patients to have access to, and to be able to rely on, accurate, relevant and comprehensive information about dry eye disease.

”TFOS has created a credible, clear and usable Summary of the TFOS DEWS II report for patients,” explained Dr. David A. Sullivan, Schepens Eye Research Institute/Harvard Medical School, and TFOS Founder. ”This Summary is written in lay language and contains new figures related to the classification and pathophysiology of dry eye disease. In the near future we also hope to make this patient-focused Executive Summary available in Wikipedia.”

The following individuals helped create this patient-focused document: Etty Bitton, OD (Canada), Stephen Cohen, OD (USA), Jennifer P Craig, MCOptom, PhD (New Zealand), Arthur Epstein, OD (USA), Preeya K Gupta, MD (USA), Katherine M Hammitt, MA (USA), Lyndon Jones, FCOptom, PhD (Canada), Allison Porreco Levesque (USA), Cecilia Marini, MD (Argentina), J Daniel Nelson, MD (USA), Leslie O’Dell, OD (USA), Colin Parsloe, MD (UK), Christina Perry (USA), Joanne Shen, MD (USA), Fiona J Stapleton, MCOptom, PhD (Australia), Christopher Starr, MD (USA), Leejee H Suh, MD (USA), Amy Gallant Sullivan (USA), David A Sullivan, PhD (USA), Mark DP Willcox, PhD, DSc (Australia) and James Wolffsohn, FCOptom PhD (UK).

The goal of the TFOS DEWS II initiative, which took over 2 years and involved 150 experts, was to achieve a global consensus concerning multiple aspects of dry eye disease. More specifically, TFOS DEWS II sought to update the definition and classification of this disease; evaluate critically the epidemiology, pathophysiology, mechanism, and impact of this disorder; develop recommendations for the diagnosis, management and therapy of this disease; and recommend the design of clinical trials to assess future interventions for dry eye disease treatment. The TFOS DEWS II initiative was very important, because dry eye disease is a global problem, afflicting hundreds of millions people around the world, and is one of the most frequent causes of patient visits to eye care practitioners.

TFOS published the TFOS DEWS II Report in The Ocular Surface journal in July 2017. Since then, TFOS has organized events and seminars around the world to increase awareness about the conclusions and recommendations of TFOS DEWS II. The patient version of the TFOS DEWS II Executive Summary is available in the patient section of the TFOS website: https://bit.ly/2MbHHrk

TFOS again thanks the following industry partners who supported TFOS DEWS II with unrestricted donations, including: Alcon, Novartis Pharmaceuticals Corporation, Shire, Allergan, Bausch+Lomb, Akorn, CooperVision, Dompé, Horus Pharma, Lµbris Biopharma, Oculeve, TearLab, Laboratoires Théa, SIFI, Johnson & Johnson Vision, Quint Health, Scope Ophthalmics, Sun Pharma, Carl Zeiss Meditec, Inc. ZEISS Group, and Senju.

About TFOS
Founded in 2000, the Tear Film & Ocular Surface Society is a world leader in eye health education headquartered in Boston. A 501(c)3 non-profit foundation, TFOS is dedicated to advancing the research, literacy, and educational aspects of the scientific field of the eye’s surface. More information about TFOS and the TFOS DEWS II Report, visit www.tearfilm.org.

# # #
 

DEWS IIdry eyedry eye diseasedry eye disease (DED)eyeeye careeye healtheyeinfoeyetipsinnovationlife sciencemeibomian glandocular surfaceophthalmologyoptometrySjögren’s Syndrome (SS)tear filmtear osmolaritytearfilmtfosTFOS DEWS IITFOS DEWS II Report
Tweet
TFOS DEWS II Impact: The Ocular Surface Impact Factor
TFOS Ambassador Meeting Update: September

About the Author

admin

You Might Also Like

  • A Lifestyle Epidemic: Ocular Surface Disease

  • TFOS Ambassador Meeting Update: September

  • TFOS DEWS II Impact: The Ocular Surface Impact Factor

  • TFOS Ambassador Meeting

    OUR VISION

    OUR VISION
    To promote further progress in this field of vision research to promote better understanding of the tear film and ocular surface

    Subscribe & Follow

    Our Tweet

    Latest News

    • A Lifestyle Epidemic: Ocular Surface Disease

      2 December 2020
    • TFOS 2020 Conference Cancellation

      4 June 2020
    • Note to the TFOS Community RE: COVID-19

      19 March 2020
    • TFOS Conference Abstract Submission Open!

      3 February 2020
    • TFOS 2020 Conference Registration Open!

      10 December 2019

    Categories

    • 3d printing
    • Android
    • art
    • artificial tears
    • ARVO
    • beauty
    • blind
    • Cardiovascular Disease
    • Cataract / IOL
    • CLDW
    • Contact lens
    • Contact Lens Discomfort
    • contact lenses
    • cosmetics
    • dermatology
    • DEWS II
    • Diagnoses
    • dry eye
    • Dry Eye Disease
    • education
    • Epidemiology
    • eye
    • eyecare
    • eyehealth
    • eyeinfo
    • EyeNetra
    • eyetips
    • Glaucoma
    • Halloween
    • Health
    • holistic
    • In Your Practice
    • innovation
    • iPad
    • iPhone
    • Laser Vision Correction
    • Latest News
    • lifescience
    • makeup
    • MGD
    • mHealth
    • MIT Media Labs
    • natural
    • Neurobiology
    • New Technology
    • Nutrition
    • ocular surface & adnexa
    • Ocular Surface Disease
    • ocular surface research
    • ophthalmolgy
    • ophthalmology
    • optometry
    • Oral Supplements
    • Prescription drops
    • Research
    • science
    • Sjögrens
    • skin care
    • smartphone
    • startups
    • tear film
    • technology
    • tfos
    • TFOS 2020
    • TFOS 2020 Conference
    • TFOS courses
    • TFOS DEWS II
    • TFOS DEWS II Report
    • TFOS Travel Awards
    • Tooteko
    • Treatment
    • Upcoming Meetings
    • vision
    • visual acuity
    • visual impairment
    • visually impaired
    • women's health
    • World Ophthalmology Congress

    Tags

    DEWS II dry eye dry eye disease (DED) eye eye care eyecare eye health eyeinfo eyetips innovation life science ophthalmology tear film tfos

    Made with in Boston

    Tear Film & Ocular Surface Society - P.O. Box 130146 - Boston, MA 02113 USA